BSE · 544013
KK Shah Hospitals Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹10 Cr with net profit ₹-1 Cr — a -6.47% net margin, versus -3.42% the period before.
Shareholding
As of 2026-03-31
- Promoter71.36%
- Public28.64%
362 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.79× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #48 of 79 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,28,572 Cr | 242.86 | 13.56 | 20.48% | 7.7% |
| Max Healthcare Institute Ltd. | ₹1,08,264 Cr | 316.02 | 10.07 | 13.42% | 17.23% |
| Fortis Healthcare Ltd. | ₹72,046 Cr | 271.11 | 7.28 | 10.53% | 11.41% |
| Aster DM Healthcare Ltd. | ₹42,460 Cr | 301.29 | 9.28 | 8.48% | 8.36% |
| Narayana Hrudayalaya Ltd. | ₹42,258 Cr | 187.64 | 9.31 | 17.76% | 10.2% |
| Global Health Limited | ₹38,523 Cr | 267.31 | 9.72 | 14.05% | 12.62% |
| Krishna Institute of Medical Sciences Ltd. | ₹31,931 Cr | 752.83 | 14.2 | 10.74% | 6.18% |
| Dr. Lal Path Labs Ltd. | ₹31,568 Cr | 239.58 | 12.58 | 20.13% | 18.27% |
| Poly Medicure Ltd. | ₹17,033 Cr | 256.95 | 5.48 | 10.37% | 17.18% |
| Dr. Agarwal's Health Care Limited | ₹15,504 Cr | 391.28 | 7.65 | 6.58% | 6.4% |
| KK Shah Hospitals Limited(this company) | ₹27 Cr | — | 2.08 | -4.87% | 0% |
AI analysis
AI-generated · google/gemini-2.5-flashKK Shah Hospitals Limited is listed with a market capitalization of Rs 27 Cr. The company reported revenue of Rs 9.55 Cr and a net profit margin of 0% for the most recent period. The 52-week high for the share price is Rs 51.9 and the 52-week low is Rs 29.
Positives
- +The company has a low debt-to-equity ratio of 0.
- +Promoter holding is high at 71.3595% as of March 31, 2026.
Negatives
- −The company reported a negative Return on Equity (ROE) of -486.9%.
- −Return on Capital Employed (ROCE) is negative at -5.6952%.
- −The company experienced a net loss of Rs -0.3272 Cr in Mar 2025, a decrease from a net profit of Rs 0.6072 Cr in Mar 2024.
- −The profit margin is 0% for the most recent period.
- −Earnings per share (EPS) is 0.
Financial Performance
KK Shah Hospitals Limited reported revenue of Rs 9.55 Cr for the latest fiscal year. Net profit stood at Rs -0.3272 Cr for Mar 2025, a decrease from Rs 0.6072 Cr in Mar 2024. Earnings per share (EPS) for the same period was -0.48. In the quarter ending Jun 2023, revenue was Rs 1.62 Cr with a net profit of Rs 0.1 Cr.
Profitability & Returns
The company's Return on Equity (ROE) is -486.9%, indicating significant losses relative to equity. Return on Capital Employed (ROCE) is -5.6952%. The profit margin for the recent period is 0%. The EPS reported is 0.
Balance Sheet
KK Shah Hospitals Limited has a book value of Rs 18.78 per share. The debt-to-equity ratio is 0, indicating the company has no reported debt. No dividend yield is reported for the company (0%).
Ownership & Pledges
As of March 31, 2026, promoters held 71.3595% of the shares. Public shareholding stood at 28.6405%. There is no reported promoter pledge (0%). The number of shareholders as of March 31, 2026, was 362.
Shareholding History
Promoter holding has remained consistent at 71.3595% from Nov 2023 to Mar 2026. However, it decreased from 100% in Mar 2023. Public shareholding, which was 0% in Mar 2023, increased to 28.6405% by Nov 2023 and has remained at that level until Mar 2026.
Data as of — price: 2026-07-29 · financials: Mar 26 · shareholding: Mar 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.